Blistering Skin Disease Pathology — Pemphigus and Pemphigoid

PEMPHIGUS: Autoantibody-Mediated Acantholysis

• Circulating IgG autoantibodies against desmosomal cadherins: The pathogenic mechanism involves IgG antibodies (primarily IgG1 and IgG3 subtypes) directed against desmogleins (Dsg), transmembrane glycoproteins that form the adhesive core of desmosomes. In pemphigus vulgaris, antibodies target Dsg3 (and frequently Dsg1 in mucocutaneous disease). In pemphigus foliaceus, antibodies exclusively target Dsg1, which is localized to superficial epidermis. The "desmoglein compensation theory" explains clinical presentation: Dsg1 antibodies alone cause superficial pemphigus foliaceus, while Dsg3 antibodies cause mucosal involvement, and combined Dsg1 + Dsg3 antibodies cause more extensive mucocutaneous disease (pemphigus vulgaris).

• Acantholysis mechanism—direct and complement-independent pathways: Antibody binding to desmogleins disrupts intercellular adhesion through steric hindrance of adhesive interactions and cross-linking of desmogleins, triggering both direct signaling and complement-dependent mechanisms. Remarkably, acantholysis in pemphigus is largely complement-independent (unlike pemphigoid), instead involving antibody-mediated activation of Src kinase family members and p38 mitogen-activated protein kinase (MAPK) signaling pathways. This leads to dysregulation of calcium homeostasis, loss of desmoglein-mediated adhesion, and increased apoptosis. Acantholysis (loss of cell-to-cell adhesion) results in intraepidermal blister formation—cells within the blister floor ("acantholytic cells") lose contact with neighbors but retain attachment to the basement membrane.

• Loss of desmoglein-mediated adhesion function: The cardinal histological finding is intraepidermal acantholysis, which can occur at varying levels depending on the desmoglein targeted. In pemphigus foliaceus, blister formation occurs subcorneal (just beneath the stratum corneum) because Dsg1 is most abundant superficially. In pemphigus vulgaris, blisters form suprabasal (immediately above the basal layer), as Dsg3 is predominant in lower epidermis. The acantholytic cells appear rounded and hyperchromatic with prominent nuclei, often described as resembling "tombstones" when viewed in cross-section (though this term is more commonly applied to invasive carcinoma, it is sometimes used descriptively in acantholysis).

PEMPHIGOID: Complement-Mediated Subepidermal Blister Formation

• IgG and IgA autoantibodies targeting hemidesmosomes: Bullous pemphigoid involves IgG autoantibodies (IgG1 and IgG4) directed against BP180 (collagen XVII, a transmembrane component of hemidesmosomes) and BP230 (a plakin-family protein). These proteins are crucial for anchoring the epidermis to the basement membrane zone (BMZ). Linear IgA disease features IgA autoantibodies against various epitopes including BP180 and other dermal antigens. Pemphigoid gestationis, occurring during pregnancy, involves IgG antibodies against BP180, with disease activity often correlating with placental expression of BP180.

• Complement activation and inflammatory infiltrate-driven blister formation: In contrast to pemphigus, pemphigoid is complement-dependent. Antibody binding to hemidesmosomes activates the classical complement cascade (C1q binding), generating C3a and C5a chemotactic fragments that recruit neutrophils and eosinophils to the dermal-epidermal junction. Degranulation of these inflammatory cells releases serine proteases, matrix metalloproteinases (particularly MMP-9), and reactive oxygen species that cleave components of the basement membrane zone and hemidesmosomes. This results in a subepidermal blister with an intact basal cell layer attached to the blister roof (the roof is the full-thickness epidermis, the floor is the basement membrane/dermis).

• Tissue-bound IgG deposits at the basement membrane zone: Immunofluorescence microscopy reveals linear IgG deposition along the basement membrane zone (contrasting with the intercellular pemphigus pattern). The deposition pattern helps distinguish the specific pemphigoid variant.

PEMPHIGUS

• Pemphigus vulgaris: Idiopathic in most cases, though rare associations include medications (ACE inhibitors, penicillamine, NSAIDs, thiuram derivatives), neoplasia (malignancy in ~5-10%, particularly lymphoproliferative disorders), and possible infectious triggers (Staphylococcus aureus, Candida, herpes simplex virus). Genetic predisposition linked to **HLA-DRB1*0402 and HLA-DQB1*0503**.

• Pemphigus foliaceus: Often drug-induced ("drug-induced pemphigus foliaceus"), most commonly by penicillamine, captopril, or thiuram compounds (found in rubber products). Idiopathic pemphigus foliaceus also occurs. Rare paraneoplastic forms exist. Higher incidence in certain geographic regions (endemic pemphigus foliaceus in Brazil associated with arthropod exposure, though causative agent debated).

• Paraneoplastic pemphigus (pemphigus paraneoplasticus): Associated with lymphoproliferative malignancies (non-Hodgkin lymphoma most common, but also Hodgkin lymphoma, chronic lymphocytic leukemia, Castleman disease). Unique feature: antibodies against multiple antigens including desmogleins, envoplakin, periplakin, and alpha-2-macroglobulin, resulting in polymorphous clinical presentation with oral erosions, severe dermatitis, and often bronchiolitis obliterans (paraneoplastic pemphigus-associated severe lung disease).

PEMPHIGOID

• Bullous pemphigoid: Typically idiopathic in elderly patients (peak incidence 6th-7th decades). Drug associations include diuretics (furosemide), antibiotics (penicillins, fluoroquinolones), NSAIDs, and beta-blockers. Rare genetic variants involve mutations in ITGA6 (integrin alpha-6) or COL17A1 (collagen XVII), causing hereditary bullous pemphigoid.

• Pemphigoid gestationis (herpes gestationis): Pregnancy-associated condition, typically second or third trimester, often flares postpartum despite hormone withdrawal. Associations with oral contraceptive use and rarely with trophoblastic disease. Recurs in subsequent pregnancies in ~33% of cases. HLA-DR3 association.

• Linear IgA disease: Idiopathic in adults; drug-induced in ~10% of cases (antibiotics—vancomycin, penicillins; NSAIDs; other agents). Pediatric linear IgA disease may follow certain infections or drug exposure.

PEMPHIGUS VULGARIS

• Oral mucosal involvement—earliest manifestation: Painful erosions and ulcerations of the oral mucosa (palate, gingiva, buccal mucosa) occur in >90% of patients and are often the first clinical sign, sometimes preceding skin involvement by weeks to months. Lesions are exquisitely painful and impair eating and drinking.

• Flaccid blisters and erosions on skin: Blisters are fragile and flaccid, rupturing easily upon minimal trauma to leave painful erosions. Initial sites include flexural areas, intertriginous zones, chest, and areas of friction. The Nikolsky sign is positive (gentle lateral pressure on skin results in epidermis sloughing away), reflecting loss of intercellular adhesion throughout the epidermis.

• Progressive, extensive involvement: Untreated disease progresses from localized to generalized distribution. Mucosal involvement is characteristic and often more prominent than in pemphigoid.

• Paraneoplastic variant: In addition to oral and cutaneous involvement, patients with paraneoplastic pemphigus develop severe, intractable dermatitis, often with exfoliative erythroderma, prominent respiratory involvement (polymorphous eruption of bronchi and bronchioles—bronchiolitis obliterans) causing cough and dyspnea, and systemic symptoms.

PEMPHIGUS FOLIACEUS

• Superficial blisters and crusting: Lesions are more superficial than pemphigus vulgaris, often appearing as flaccid blisters or erosions with crusting (crusts form more readily due to subcorneal location). Blisters readily rupture to leave crusted erosions.

• Seborrheic distribution: Lesions often involve face (especially nasiolabial folds, cheeks), chest, shoulders, and intertriginous areas in a pattern mimicking seborrheic dermatitis.

• Minimal mucosal involvement: Unlike pemphigus vulgaris, oral mucosal involvement is rare or absent because Dsg1 (not Dsg3) is the target antigen, and Dsg1 is sparse in mucosa where Dsg3 predominates.

• Positive Nikolsky sign: Present due to intraepidermal acantholysis.

BULLOUS PEMPHIGOID

• Tense blisters on flexural and lower abdominal skin: Blisters are tense and firm, with intact overlying epidermis (the blister floor is at the dermal-epidermal junction), contrasting sharply with flaccid pemphigus blisters. Classic sites include inner thighs, flexural areas, lower abdomen, inguinal folds, and dorsal forearms.

• Urticarial or eczematous precursors: Often precedes frank blistering by weeks; lesions may resemble hives, eczema, or papular erythema.

• Painful erosions following blister rupture: Although blisters are initially intact, they eventually rupture to form painful erosions.

• Minimal mucosal involvement: Oral involvement is less common than in pemphigus vulgaris, occurring in ~10-30% of cases.

• Negative or weakly positive Nikolsky sign: Unlike pemphigus, the Nikolsky sign is typically negative or only weakly positive because the epidermis is attached to the basement membrane; only the epidermal-dermal junction is disrupted.

LINEAR IgA DISEASE

• Annular or arcuate lesions—"string of pearls": Classic presentation features grouped vesicles and blisters arranged in an annular pattern around the periphery of an erythematous plaque, described as a "string of pearls" appearance (particularly in drug-induced cases).

• Variable clinical presentation: Lesions may resemble pemphigoid or manifest with polymorphous morphology including urticaria, papules, vesicles, and blisters. Distribution is often generalized.

• GI and ocular involvement: Unlike other pemphigoids, linear IgA disease frequently involves mucous membranes (10-40% of patients), including mouth, esophagus, conjunctiva, and anogenital region. Conjunctival involvement with pseudomembrane formation and scarring can lead to cicatricial pemphigoid-like changes.

PEMPHIGOID GESTATIONIS

• Urticarial papules and vesicles in periumbilical region: Typically begins around the umbilicus and lower abdomen in the second or third trimester, with spread to flexures and extremities. Morphology ranges from urticarial papules to frank blisters; oral mucosa is typically spared.

• Postpartum flare: Disease often worsens or new lesions appear in the immediate postpartum period despite declining hormone levels (paradoxical timing).

• Neonatal involvement in rare cases: Passive transfer of maternal IgG may cause transient neonatal blisters (typically resolving within 3 weeks as maternal antibody clears).

• Pruritus predominates: Intense itching is often the primary symptom, preceding visible lesions.

HISTOPATHOLOGY

Pemphigus (Intraepidermal Acantholysis)

• Acantholysis: The hallmark finding is loss of intercellular connections (desmosomes), resulting in separated, rounded acantholytic cells within the epidermis. In pemphigus foliaceus, acantholysis is subcorneal (just beneath stratum corneum), creating a very superficial intraepidermal blister. In pemphigus vulgaris, acantholysis is suprabasal (immediately above basal layer), creating a higher intraepidermal blister. The blister floor retains basal cells (these cells remain attached to the basement membrane by hemidesmosomes).

• Acantholytic cells: These are rounded, hyperchromatic epithelial cells suspended in the blister cavity with enlarged nuclei, abundant cytoplasm, and prominent nucleoli. They may resemble malignant cells but are benign; nuclear-to-cytoplasmic ratio is increased. In the blister cavity, isolated acantholytic cells are dispersed in acellular fluid.

• "Tombstone" or "row of tombstones": A descriptive term for the cross-sectional appearance of basal cells in the blister floor, appearing as a row of cells (though this term is more classically used for invasive squamous cell carcinoma and is less commonly used for pemphigus).

• Minimal or absent inflammation: Pemphigus histology typically shows minimal inflammatory infiltrate, distinguishing it from pemphigoid. Some perivascular lymphocytic infiltration may be present, but it is sparse.

• Intact basement membrane zone: The basement membrane remains intact and continuous, which is critical to the distinction from pemphigoid.

Pemphigoid (Subepidermal Blister with Inflammation)

• Subepidermal blister formation: The blister splits at the dermal-epidermal junction, with the blister roof being the full-thickness epidermis (still attached to the roof) and the blister floor being the basement membrane zone and superficial dermis. This contrasts sharply with the intraepidermal location in pemphigus.

• Dense inflammatory infiltrate: Pemphigoid demonstrates a prominent inflammatory cell infiltrate at the dermal-epidermal junction and in the superficial dermis, typically with a mixture of:
• Neutrophils (particularly abundant immediately at the blister base and in the BMZ)
• Eosinophils (often prominent in bullous pemphigoid, may be numerous in the dermis)
• Lymphocytes (T cells and B cells)
• Plasma cells

• Eosinophilic microabscesses: Collections of neutrophils and eosinophils form at the BMZ and are sometimes called "eosinophilic spongiosis" or "eosinophilic microabscesses" when prominent.

• Linear IgA disease: Histology resembles bullous pemphigoid with a subepidermal bl

Immediate stabilisation (extensive erosive disease)

• Barrier failure care: widespread denuded skin behaves like a partial-thickness burn — isotonic fluid and electrolyte repletion, non-adherent dressings, temperature control, and nutritional support (oral erosions cause protein-calorie deficit). Extensive pemphigus vulgaris warrants inpatient or burn-unit level care and surveillance cultures for Staphylococcus aureus and herpes simplex.
• Withdraw the culprit drug: thiol-containing agents (penicillamine, captopril and other ACE inhibitors) in pemphigus, vancomycin in linear IgA disease, and DPP-4 inhibitors ("gliptins") or PD-1/PD-L1 inhibitors in bullous pemphigoid. Discontinuation alone may induce remission in drug-induced disease.

First-line therapy — pemphigus vulgaris/foliaceus

• Anti-CD20 monoclonal antibody (rituximab) plus a systemic corticosteroid (prednisone): B-cell depletion removes the desmoglein-specific autoantibody-producing clones. The 2020 updated international consensus on pemphigus management endorses rituximab as first-line for moderate-to-severe disease, and it carries FDA approval for pemphigus vulgaris; corticosteroids bridge the several-week lag until B-cell depletion takes effect.
• Steroid-sparing antimetabolites (azathioprine, mycophenolate mofetil): used to taper corticosteroid exposure. Check TPMT/NUDT15 activity before azathioprine.

First-line therapy — bullous pemphigoid

• Superpotent topical corticosteroid (clobetasol propionate 0.05%) applied whole-body: randomized trial data cited by the European S3 (EADV/EDF) guideline show efficacy at least equal to oral corticosteroids with less systemic toxicity in elderly patients.
• Tetracycline-class antibiotic (doxycycline), often with nicotinamide: anti-inflammatory/anti-chemotactic, non-inferior for initial blister control (BLISTER trial) and preferred when steroid toxicity is a concern.
• Dapsone is first-line for linear IgA disease and for neutrophil-rich pemphigoid — screen G6PD first.

Contraindicated

• Live vaccines during immunosuppression; screen for hepatitis B and latent TB before rituximab (reactivation risk).
• Methotrexate, mycophenolate, cyclophosphamide, and tetracyclines in pregnancy — pemphigoid gestationis is treated with topical corticosteroids escalating to prednisone, consistent with ACOG principles of using the least teratogenic effective agent.

Disease-related

• Sepsis from secondary bacterial infection (emergency): loss of the epidermal barrier over large surface areas permits Staphylococcus aureus and Pseudomonas invasion. Signalled by new purulent or malodorous erosions, fever, hypotension, or leukocytosis in a patient whose blistering was previously stable. Historically the leading cause of death in untreated pemphigus vulgaris.
• Fluid, electrolyte, and protein loss (emergency when extensive): transepidermal water loss from denuded skin produces hypovolemia, hypernatremia, and hypoalbuminemia; watch urine output and rising creatinine.
• Herpes simplex superinfection: presents as abrupt worsening with monomorphic punched-out erosions in a patient on immunosuppression; Tzanck smear or PCR confirms and it is a common reason for apparent "treatment failure."
• Malnutrition and dehydration from oral erosions: painful mucosal disease limits intake; a marker of active Dsg3-driven disease.
• Bronchiolitis obliterans in paraneoplastic pemphigus (emergency): autoantibody-mediated respiratory epithelial injury produces irreversible small-airway obstruction; progressive dyspnea with fixed obstruction on spirometry, frequently fatal.
• Cicatricial (scarring) complications of mucosal pemphigoid variants: conjunctival fibrosis with symblepharon and entropion threatens vision; esophageal or laryngeal strictures cause dysphagia or stridor.
• Venous thromboembolism and functional decline: bullous pemphigoid occurs in frail elderly patients and carries substantial one-year mortality driven by immobility, infection, and comorbidity rather than the blisters themselves.

Treatment-related

• Systemic corticosteroid toxicity: hyperglycemia, hypertension, osteoporosis with vertebral fracture, avascular necrosis of the femoral head, cataracts, psychosis, and HPA-axis suppression with adrenal crisis if stopped abruptly. Prolonged high-dose therapy warrants Pneumocystis jirovecii prophylaxis (trimethoprim-sulfamethoxazole) and bone protection.
• Rituximab: hypogammaglobulinemia with recurrent sinopulmonary infection, infusion reactions, hepatitis B reactivation (screen HBsAg/anti-HBc beforehand), and rare progressive multifocal leukoencephalopathy.
• Dapsone: dose-dependent hemolysis, severe in G6PD deficiency; methemoglobinemia — cyanosis with a normal PaO2 and low pulse oximetry that fails to correct with oxygen; also agranulocytosis and a DRESS-like hypersensitivity syndrome.
• Azathioprine: profound myelosuppression in TPMT or NUDT15 deficiency; long-term non-melanoma skin cancer and lymphoma risk.
• Mycophenolate and methotrexate: cytopenias, hepatotoxicity, and teratogenicity.

• Level of split drives everything: flaccid blisters + positive Nikolsky sign + oral erosions = intraepidermal (pemphigus); tense blisters + negative Nikolsky in an elderly patient = subepidermal (pemphigoid). Tense blisters resist rupture because the entire epidermis forms the roof.
• The single best next step is a biopsy for direct immunofluorescence taken from perilesional, normal-appearing skin, paired with lesional skin for H&E. DIF on the blister itself is a classic wrong answer — inflammatory destruction degrades the immunoreactants. Serum ELISA for anti-Dsg1/Dsg3 or anti-BP180 supports the diagnosis and tracks activity.
• DIF patterns are the money question: "fishnet" / "chicken-wire" intercellular IgG and C3 throughout the epidermis in pemphigus versus linear IgG and C3 along the basement membrane zone in bullous pemphigoid.
• Desmoglein compensation predicts the stem: Dsg3-only disease is mucosa-dominant; Dsg1-only disease (pemphigus foliaceus) spares the mouth and blisters subcorneally in a seborrheic distribution.
• The association examiners love: paraneoplastic pemphigus with non-Hodgkin lymphoma, CLL, or Castleman disease, presenting with intractable stomatitis plus bronchiolitis obliterans — the finding that mandates a malignancy search. Pemphigus vulgaris also links to *HLA-DRB1\*0402*.
• First-line therapy has shifted: an anti-CD20 antibody (rituximab) plus corticosteroid for pemphigus vulgaris per the international pemphigus consensus, whereas whole-body superpotent topical clobetasol — not oral prednisone — is the preferred initial therapy for bullous pemphigoid in the EADV/EDF guideline.
• Salt-split skin distinguishes the look-alikes: pemphigoid antibodies bind the epidermal roof (BP180/BP230); epidermolysis bullosa acquisita antibodies bind the dermal floor (collagen VII).
• Common distractors: dermatitis herpetiformis shows granular IgA in dermal papillary tips with celiac disease (gluten-free diet plus dapsone), not linear IgA; and staphylococcal scalded skin syndrome/bullous impetigo produces a subcorneal split because exfoliative toxin cleaves Dsg1 — the same target as pemphigus foliaceus, but DIF is negative.